Virpax Pharmaceuticals, Inc.
VRPXDelisted Jul 21, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708331
Virpax Pharmaceuticals, Inc. was delisted on Jul 21, 2025; its insiders filed their last Form 4 on Jul 10, 2024; 7 institutions reported holding it in 13F filings for Q1 2025, worth $34.9K in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding Virpax Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 13 | 18 | +5 |
| Shares | 616.8K | 377.2K | −239.5K (−38.8%) |
| Value | $493.4K | $120.5K | −$372.9K (−75.6%) |
New holders (6)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sheets Smith Wealth Management | 50,000 | $16.0K | 0.00% |
| Susquehanna International Group, LLP | 17,734 | $5.59K | 0.00% |
| Two Sigma Securities, LLC | 11,695 | $3.74K | 0.00% |
| JPMorgan Chase & Co | 4,358 | $1.37K | 0.00% |
| Signature Resources Capital Management, LLC | 500 | $160 | 0.00% |
| Parallel Advisors, LLC | 14 | $5 | 0.00% |
Sold out (1)
Institutions that held Virpax Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Sabby Management, LLC | 292,790 | $234.2K |